- Home
- QNCX vs SCWO Comparison
QNCX vs SCWO Comparison
Compare QNCX & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- SCWO
- Stock Information
- Founded
- QNCX 2012
- SCWO 2021
- Country
- QNCX United States
- SCWO United States
- Employees
- QNCX N/A
- SCWO N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- SCWO Environmental Services
- Sector
- QNCX Health Care
- SCWO Utilities
- Exchange
- QNCX Nasdaq
- SCWO Nasdaq
- Market Cap
- QNCX 47.7M
- SCWO 39.9M
- IPO Year
- QNCX 2019
- SCWO N/A
- Fundamental
- Price
- QNCX $1.31
- SCWO $0.36
- Analyst Decision
- QNCX Strong Buy
- SCWO
- Analyst Count
- QNCX 5
- SCWO 0
- Target Price
- QNCX $8.00
- SCWO N/A
- AVG Volume (30 Days)
- QNCX 302.6K
- SCWO 3.4M
- Earning Date
- QNCX 08-12-2025
- SCWO 08-13-2025
- Dividend Yield
- QNCX N/A
- SCWO N/A
- EPS Growth
- QNCX N/A
- SCWO N/A
- EPS
- QNCX N/A
- SCWO N/A
- Revenue
- QNCX N/A
- SCWO $673,267.00
- Revenue This Year
- QNCX N/A
- SCWO $5,945.19
- Revenue Next Year
- QNCX N/A
- SCWO $106.82
- P/E Ratio
- QNCX N/A
- SCWO N/A
- Revenue Growth
- QNCX N/A
- SCWO 161.19
- 52 Week Low
- QNCX $0.51
- SCWO $0.25
- 52 Week High
- QNCX $2.45
- SCWO $1.99
- Technical
- Relative Strength Index (RSI)
- QNCX 64.64
- SCWO 47.09
- Support Level
- QNCX $1.29
- SCWO $0.36
- Resistance Level
- QNCX $1.45
- SCWO $0.42
- Average True Range (ATR)
- QNCX 0.09
- SCWO 0.06
- MACD
- QNCX 0.03
- SCWO -0.01
- Stochastic Oscillator
- QNCX 76.74
- SCWO 1.63
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.